Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning, N Engl J Med, vol.298, pp.1384-1390, 1978. ,
Antibodies and antimatter: the resurgence of immuno-PET, J Nucl Med Off Publ Soc Nucl Med, vol.50, pp.2-5, 2009. ,
Immuno-PET of cancer: a revival of antibody imaging, J Nucl Med Off Publ Soc Nucl Med, vol.52, pp.1171-1173, 2011. ,
Immuno-PET for clinical theranostic approaches, Int J Mol Sci, vol.18, p.57, 2016. ,
URL : https://hal.archives-ouvertes.fr/in2p3-01951323
ImmunoPET to help stratify patients for targeted therapies and to improve drug development, Eur J Nucl Med Mol Imaging, vol.43, pp.2166-2174, 2016. ,
URL : https://hal.archives-ouvertes.fr/inserm-01809742
Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level, J Clin Endocrinol Metab, vol.90, pp.2029-2063, 2005. ,
Revised American thyroid association guidelines for the management of medullary thyroid carcinoma, Thyroid Off J Am Thyroid Assoc, vol.25, pp.567-610, 2015. ,
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma, Thyroid Off J Am Thyroid Assoc, vol.20, pp.527-560, 2010. ,
Complementary roles of 18 F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer, J Nucl Med Off Publ Soc Nucl Med, vol.52, pp.1855-63, 2011. ,
Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigentargeted radioimmunotherapy, J Clin Endocrinol Metab, vol.92, pp.4590-4597, 2007. ,
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma, J Nucl Med Off Publ Soc Nucl Med, vol.53, pp.1863-71, 2012. ,
Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA/anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer, J Nucl Med Off Publ Soc Nucl Med, vol.34, pp.1267-73, 1993. ,
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody, J Nucl Med Off Publ Soc Nucl Med, vol.39, pp.1172-1180, 1998. ,
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement, J Nucl Med Off Publ Soc Nucl Med, vol.53, pp.1185-92, 2012. ,
URL : https://hal.archives-ouvertes.fr/hal-00932253
Molecular imaging of HER2-expressing malignant tumors in breast cancer patients using synthetic 111 In-or 68 Ga-labeled affibody molecules, J Nucl Med Off Publ Soc Nucl Med, vol.51, pp.892-899, 2010. ,
64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer, J Nucl Med Off Publ Soc Nucl Med, vol.54, pp.1869-75, 2013. ,
89 Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer, Nat Med, vol.24, pp.1852-1860, 2018. ,
Pretargeted immuno-PET and radioimmunotherapy of prostate cancer with an anti-TROP-2 x anti-HSG bispecific antibody, Eur J Nucl Med Mol Imaging, vol.40, pp.1377-83, 2013. ,
Pretargeted imaging and therapy, J Nucl Med Off Publ Soc Nucl Med, vol.58, pp.1553-1562, 2017. ,
Pretargeted immuno-positron emission tomography imaging of carcinoembryonic antigen-expressing tumors with a bispecific antibody and a 68 Ga-and 18 F-labeled hapten peptide in mice with human tumor xenografts, Mol Cancer Ther, vol.9, pp.1019-1046, 2010. ,
A novel method of 18F radiolabeling for PET, J Nucl Med Off Publ Soc Nucl Med, vol.50, pp.991-999, 2009. ,
Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting, Proc Natl Acad Sci, vol.103, pp.6841-6847, 2006. ,
Bispecific antibody pretargeting PET (immunoPET) with an 124 Ilabeled hapten-peptide, J Nucl Med Off Publ Soc Nucl Med, vol.47, pp.1678-88, 2006. ,
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results, Br J Cancer, vol.109, pp.934-976, 2013. ,
Predictive patient-specific dosimetry and individualized dosing of pretargeted radioimmunotherapy in patients with advanced colorectal cancer, Eur J Nucl Med Mol Imaging, vol.41, pp.1593-602, 2014. ,
Targeting, toxicity, and efficacy of 2-step, pretargeted radioimmunotherapy using a chimeric bispecific antibody and 131 I-labeled bivalent hapten in a phase I optimization clinical trial, J Nucl Med Off Publ Soc Nucl Med, vol.47, pp.247-55, 2006. ,
Pharmacokinetics and dosimetry studies for optimization of pretargeted radioimmunotherapy in CEA expressing advanced lung cancer patient, Front Med Lausanne, vol.2, p.84, 2015. ,
Sensitivity of pretargeted immunoPET using 68 Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: comparison with 18FDG PET-CT, Oncotarget, vol.9, pp.27502-27515, 2018. ,
URL : https://hal.archives-ouvertes.fr/inserm-01981491
Immuno-PET using anti-CEA bispecific antibody and 68 Ga-labeled peptide in metastatic medullary thyroid carcinoma: clinical optimization of the pretargeting parameters in a First-in Human trial, J Nucl Med Off Publ Soc Nucl Med, vol.57, pp.1505-1516, 2016. ,
High sensitivity of pretargeted immuno-PET using anti-carcinoembryonic antigen (CEA) bispecific antibody and Ga-68-labeled peptide in metastatic medullary thyroid carcinoma ,
, Eur J Nucl Med Mol Imaging, vol.41, pp.314-319
Pretargeted immuno-PET with an anti-carcinoembryonic antigen (CEA) bispecific antibody (BsMAb) and a 68 Ga-labeled hapten-peptide compared to conventional imaging and FDG-PET in metastatic breast cancer patients (BC): First results, Cancer Res, vol.75, 2015. ,
Pre-targeted immuno-PET with bispecific anti-CEA antibody and Gallium-68-labeled IMP-288 peptide for imaging of metastates from colorectal cancer, JFHOD Annual Meeting, 2019. ,
Feasibility of affibody molecule-based PNA-mediated radionuclide pretargeting of malignant tumors, Theranostics, vol.6, pp.93-103, 2016. ,
In vivo chemistry for pretargeted tumor imaging in live mice, Angew Chem Int Ed Engl, vol.49, pp.3375-3383, 2010. ,